Gilead may soon buy Immunomedics in deal over $20 billion
The deal, which will expand Gilead’s oncology portfolio, might get announced tomorrow if not sooner, inform reports
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.